Live Breaking News & Updates on Ursuant Lixt Us5393192027

Stay updated with breaking news from Ursuant lixt us5393192027. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lixte Biotechnology : Termination of Material Agreement - Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO. | May 10, 2023 ....

United States , Westpark Capital Inc , Company Current Report On Form , Lixte Biotechnology Holdings Inc , Nasdaqstock Market , Securities Exchange , Exchange Commission On , Colorado Blvd Suite , General Instruction , Securities Act , Exchange Act , Purchase Common , Material Definitive , Lixte Biotechnology Holdings , Westpark Capital , Sales Agreement , Current Report , Exchange Commission , Securities Exchange Act , Nc Stock Exchange , Press Release , Ursuant Lixt Us5393192027 ,